Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes (i) 1,095,967 shares of Common Stock underlying milestone warrants held by ADAR1 Partners, LP as of February 7, 2025. Excludes 132,103 shares of Common Stock underlying milestone warrants held by ADAR1 Partners, LP, the exchange and exercise of which are subject to 9.99% beneficial ownership limitations. As the investment manager of ADAR1 Partners, LP, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP. (2) Based on 9,874,676 shares of Common Stock of iBio, Inc. (the "Issuer") outstanding as of February 7, 2025 reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2024, filed with the SEC on February 10, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes (i) 1,095,967 shares of Common Stock underlying milestone warrants held by ADAR1 Partners, LP as of February 7, 2025. Excludes 132,103 shares of Common Stock underlying milestone warrants held by ADAR1 Partners, LP, the exchange and exercise of which are subject to 9.99% beneficial ownership limitations. As the general partner of ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP. (2) Based on 9,874,676 shares of Common Stock of the Issuer outstanding as of February 7, 2025 reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2024, filed with the SEC on February 10, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes (i) 1,095,967 shares of Common Stock underlying milestone warrants held by ADAR1 Partners, LP as of February 7, 2025. Excludes 132,103 shares of Common Stock underlying milestone warrants held by ADAR1 Partners, LP, the exchange and exercise of which are subject to 9.99% beneficial ownership limitations. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP. (2) Based on 9,874,676 shares of Common Stock of the Issuer outstanding as of February 7, 2025 reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2024, filed with the SEC on February 10, 2025.


SCHEDULE 13G



 
ADAR1 Capital Management, LLC
 
Signature:/s/ Daniel Schneeberger
Name/Title:Daniel Schneeberger, Manager
Date:02/14/2025
 
ADAR1 Capital Management GP, LLC
 
Signature:/s/ Daniel Schneeberger
Name/Title:Daniel Schneeberger, Manager
Date:02/14/2025
 
Daniel Schneeberger
 
Signature:/s/ Daniel Schneeberger
Name/Title:Daniel Schneeberger, in his individual capacity
Date:02/14/2025